SCHEMBL30791200

SCHEMBL30791200

Nc1n[nH]c2nc(Nc3cccc4c3CCC4)c(F)cc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.46
▸ NISCH Q9Y2I1 1/20 0.41
▸ MEN1 O00255 1/20 0.38
▸ KCNK2 O95069 1/20 0.38
▸ KCNK10 P57789 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ KCNK18 Q7Z418 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ ULK1 O75385 1/20 0.38
▸ RXRA P19793 3/20 0.37
▸ RXRB P28702 3/20 0.37
▸ RXRG P48443 3/20 0.37
▸ PPARA Q07869 3/20 0.37
▸ PPARG P37231 2/20 0.37
▸ ALOX5 P09917 1/20 0.37
▸ CCNE2 O96020 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CCR4 P51679 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23356028 1.00 EGFR (0.46) EGFRNISCHMEN1KCNK2KCNK10
SCHEMBL23356076 0.98 EGFR (0.48) EGFRNISCHMEN1KCNK2KCNK10
SCHEMBL30791210 0.90 NISCH (0.42) EGFRNISCHMEN1KCNK2KCNK10
SCHEMBL23356021 0.90 NISCH (0.42) EGFRNISCHMEN1KCNK2KCNK10
SCHEMBL23356014 0.88 NISCH (0.43) EGFRNISCHMEN1KCNK2KCNK10
SCHEMBL23356095 0.88 NISCH (0.43) EGFRNISCHMEN1KCNK2KCNK10
SCHEMBL23356020 0.88 NISCH (0.40) EGFRNISCHMEN1KCNK2KCNK10
SCHEMBL23356024 0.88 NISCH (0.40) EGFRNISCHMEN1KCNK2KCNK10
SCHEMBL23356004 0.88 NISCH (0.40) EGFRNISCHMEN1KCNK2KCNK10
SCHEMBL30791251 0.88 NISCH (0.40) EGFRNISCHMEN1KCNK2KCNK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4703350-A1 METHOD FOR PREPARING 4-AMINOINDAN AND METHOD FOR PREPARING DIHYDROINDENYL-PYRAZOLO[3,4-B]PYRIDINE-AMINE JW Pharmaceutical Corporation (KR) 2026-03-04 — — EP claimed
EP-4703351-A1 METHOD OF PREPARING 4-AMINOINDAN AND METHOD OF PREPARING DIHYDROINDENYL-PYRAZOLO[3,4-B]PYRIDINE-AMINE COMPOUND JW Pharmaceutical Corporation (KR) 2026-03-04 — — EP claimed
EP-4703350-A1 METHOD FOR PREPARING 4-AMINOINDAN AND METHOD FOR PREPARING DIHYDROINDENYL-PYRAZOLO[3,4-B]PYRIDINE-AMINE JW Pharmaceutical Corporation (KR) 2026-03-04 — — EP disclosed
EP-4703351-A1 METHOD OF PREPARING 4-AMINOINDAN AND METHOD OF PREPARING DIHYDROINDENYL-PYRAZOLO[3,4-B]PYRIDINE-AMINE COMPOUND JW Pharmaceutical Corporation (KR) 2026-03-04 — — EP disclosed
WO-2024224297-A1 METHOD FOR PREPARING 4-AMINOINDAN AND METHOD FOR PREPARING DIHYDROINDENYL-PYRAZOLO[3,4-B]PYRIDINE-AMINE 제이더블유중외제약 주식회사 2024-10-31 — — WO disclosed
WO-2024224298-A1 METHOD OF PREPARING 4-AMINOINDAN AND METHOD OF PREPARING DIHYDROINDENYL-PYRAZOLO[3,4-B]PYRIDINE-AMINE COMPOUND 제이더블유중외제약 주식회사 2024-10-31 — — WO disclosed
CN-112313232-B Novel heterocyclic derivatives JW中外制药公司 2024-03-08 — — CN disclosed
Send feedback